Clinical Trials Browser

Glioblastoma

NCT06607692 2026-04-14

LUPARPED

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT04528680 2026-04-13

SC9/ABX

Phase 1/2 Active not recruiting

57 enrolled

CNSSarcoma

Glioblastoma, Gliosarcoma

NCT07468136 2026-04-13

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Phase 1/2 Not yet recruiting

33 enrolled

CNSLymphoid

Astrocytoma, Glioblastoma, Glioma, Lymphoma, Follicular, Oligodendroglioma

Clinical Trials

STERIMGLI

LUPARPED

SC9/ABX

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM)

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

DENDR1

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma

NAVIG-1

SELECT-CAR-NK

EBNK-ST-001

GEINOCANN

Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)

5G-PEARL

Study of Pembrolizumab and M032 (NSC 733972)

5G-RUBY

Study of Niacin in Glioblastoma

Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma

Clinical Study of Oncolytic Virus in Glioblastoma

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

GlitIpNi

RABBIT

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

D2C7-IT and 2141-V11 in Newly Diagnosed GBM Patients

Atezolizumab in Combination With Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

DLL3 CAR-T Therapy Targeting Brain Tumors

A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

PriCoTTF

IA Carboplatin + Radiotherapy in Relapsing GBM

Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma

PAZOGLIO

IceCAP

IMA950-106

PRIDE

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

CAPTEM

PD-L1-PET

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

NANO-GBM

BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations

ALA-RDTinGBM

Dendritic Cell Vaccination for Patients with Solid Tumors

BAH2472

A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70